Most sold healthcare stocks in Q4 2021
See which Healthcare stocks institutional investors trimmed or exited the most in Q4 2021, measured as net reductions in reported share positions from Q3 2021 into Q4 2021. Notable reductions at the top of this list include TEVA PHARMACEUTICAL-SP ADR (TEVA), BRISTOL-MYERS SQUIBB CO (BMY), ABBVIE INC (ABBV), PFIZER INC (PFE). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| TEVA | TEVA PHARMACEUTICAL-SP ADR | -42,111,459 | -$471.07M | 1 | 2 | 3 | 1 | 7 |
| BMY | BRISTOL-MYERS SQUIBB CO | -24,832,492 | -$1.32B | 5 | 7 | 11 | 0 | 25 |
| ABBV | ABBVIE INC | -11,267,673 | -$1.03B | 2 | 8 | 6 | 0 | 19 |
| PFE | PFIZER INC | -10,735,254 | -$13.65M | 3 | 7 | 8 | 3 | 20 |
| WRBY | WARBY PARKER INC-CLASS A | -9,521,333 | -$592.71M | 2 | 1 | 1 | 0 | 4 |
| TAK | TAKEDA PHARMACEUTIC-SP ADR | -6,470,541 | -$136.68M | 0 | 1 | 4 | 0 | 5 |
| SENS | SENSEONICS HOLDINGS INC | -5,077,500 | -$18.90M | 0 | 0 | 1 | 0 | 1 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | -4,180,924 | -$145.29M | 1 | 0 | 3 | 0 | 4 |
| MRNA | MODERNA INC | -3,391,217 | -$1.60B | 3 | 3 | 2 | 4 | 8 |
| FATE | FATE THERAPEUTICS INC | -2,786,654 | -$173.04M | 1 | 1 | 1 | 1 | 3 |
| JNJ | JOHNSON & JOHNSON | -2,699,919 | -$248.29M | 3 | 8 | 10 | 0 | 28 |
| CDXS | CODEXIS INC | -2,589,461 | -$34.25M | 0 | 0 | 1 | 0 | 1 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | -2,485,633 | $67.94M | 3 | 1 | 2 | 1 | 7 |
| BHC | BAUSCH HEALTH COS INC | -2,314,083 | -$77.47M | 0 | 4 | 2 | 1 | 6 |
| PGEN | PRECIGEN INC | -1,990,519 | -$18.26M | 0 | 0 | 2 | 0 | 2 |
| AGL | AGILON HEALTH INC | -1,879,119 | -$44.46M | 1 | 0 | 1 | 1 | 2 |
| EDIT | EDITAS MEDICINE INC | -1,851,000 | -$140.65M | 1 | 0 | 1 | 1 | 2 |
| UNH | UNITEDHEALTH GROUP INC | -1,543,781 | $1.80B | 2 | 9 | 16 | 2 | 30 |
| ASND | ASCENDIS PHARMA A/S - ADR | -1,435,418 | -$229.20M | 1 | 1 | 0 | 1 | 2 |
| CNC | CENTENE CORP | -1,428,970 | $89.79M | 2 | 0 | 5 | 0 | 7 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | -1,338,508 | -$272.05M | 3 | 6 | 3 | 3 | 12 |
| IONS | IONIS PHARMACEUTICALS INC | -1,309,639 | -$66.76M | 0 | 2 | 2 | 1 | 4 |
| DXCM | DEXCOM INC | -1,294,765 | -$710.07M | 1 | 4 | 0 | 1 | 5 |
| LFST | LIFESTANCE HEALTH GROUP INC | -1,201,647 | -$18.04M | 1 | 0 | 0 | 1 | 1 |
| ELV | ELEVANCE HEALTH INC | -1,187,975 | $354.81M | 1 | 2 | 10 | 1 | 15 |
| AZN | ASTRAZENECA PLC-SPONS ADR | -1,101,507 | -$78.98M | 1 | 1 | 5 | 0 | 8 |
| VRTX | VERTEX PHARMACEUTICALS INC | -1,078,096 | -$69.13M | 1 | 1 | 6 | 0 | 9 |
| AVIR | ATEA PHARMACEUTICALS INC | -1,056,387 | -$53.28M | 0 | 2 | 0 | 1 | 2 |
| ZTS | ZOETIS INC | -1,005,181 | $521.74M | 1 | 8 | 4 | 0 | 14 |
| NKTR | NEKTAR THERAPEUTICS | -1,000,000 | -$18.47M | 0 | 0 | 0 | 1 | 1 |
| MRK | MERCK & CO. INC. | -955,501 | -$56.57M | 2 | 9 | 8 | 2 | 23 |
| BAX | BAXTER INTERNATIONAL INC | -903,767 | -$64.33M | 1 | 1 | 6 | 1 | 11 |
| INCY | INCYTE CORP | -900,788 | $44.17M | 0 | 2 | 5 | 0 | 7 |
| CTXR | CITIUS PHARMACEUTICALS INC | -888,501 | -$1.80M | 0 | 0 | 0 | 1 | 0 |
| CVS | CVS HEALTH CORP | -855,777 | $233.56M | 3 | 3 | 10 | 1 | 17 |
| CLLS | CELLECTIS - ADR | -841,207 | -$23.82M | 0 | 0 | 1 | 0 | 1 |
| LLY | ELI LILLY & CO | -832,361 | -$124.68M | 2 | 4 | 5 | 1 | 12 |
| OPK | OPKO HEALTH INC | -826,082 | -$2.79M | 1 | 0 | 0 | 1 | 2 |
| CERS | CERUS CORP | -794,927 | $6.97M | 0 | 1 | 1 | 0 | 2 |
| ALHC | ALIGNMENT HEALTHCARE INC | -775,658 | -$13.27M | 1 | 0 | 1 | 0 | 2 |
| PSNL | PERSONALIS INC | -764,958 | -$39.01M | 0 | 0 | 1 | 1 | 1 |
| CSTL | CASTLE BIOSCIENCES INC | -710,379 | -$79.08M | 1 | 0 | 1 | 0 | 2 |
| SNY | SANOFI-ADR | -678,756 | $145.23M | 1 | 4 | 2 | 0 | 7 |
| ARAY | ACCURAY INC | -648,500 | $134.00K | 0 | 0 | 1 | 0 | 1 |
| MOH | MOLINA HEALTHCARE INC | -623,355 | -$58.21M | 1 | 1 | 3 | 0 | 5 |
| CMRX | CHIMERIX INC | -622,805 | -$3.47M | 0 | 0 | 1 | 0 | 1 |
| NVS | NOVARTIS AG-SPONSORED ADR | -526,317 | $149.31M | 2 | 4 | 5 | 0 | 12 |
| TXG | 10X GENOMICS INC-CLASS A | -515,978 | -$65.58M | 1 | 1 | 4 | 0 | 7 |
| CYH | COMMUNITY HEALTH SYSTEMS INC | -489,000 | -$5.06M | 0 | 1 | 1 | 1 | 2 |
| MLSS | MILESTONE SCIENTIFIC INC | -470,392 | -$850.00K | 0 | 0 | 1 | 0 | 1 |
Frequently asked questions about Most sold healthcare stocks in Q4 2021
What are the most sold Healthcare stocks in Q4 2021?
The most sold healthcare stocks in Q4 2021 are those with the largest decrease in reported share counts across institutional investors compared to Q3 2021, based on SEC 13F filings.
Which healthcare stocks did institutional investors trimmed or exited the most in Q4 2021?
Among filers in this sector, net reductions were largest in companies such as TEVA PHARMACEUTICAL-SP ADR (TEVA), BRISTOL-MYERS SQUIBB CO (BMY), ABBVIE INC (ABBV), based on aggregated 13F data.
How is institutional selling calculated?
Selling is calculated by summing the net decrease in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q3 2021).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.